Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and ...
A single dose of experimental gene therapy GS001 reduced bleeding episodes in men with severe hemophilia A, a study showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results